Bonum Therapeutics
Latest round
- Series A
Last raised
- Nov 2022
Total raised
- $45M
Investors
- 6
About Bonum Therapeutics
Based in Seattle, US, and founded in 2021, Bonum Therapeutics, Inc. is a biotechnology company developing protein-based drugs that can sense and respond to their local environment. In December 2021, Bonum Therapeutics, Inc. Bonum Therapeutics develops protein-based drugs with regulated, and context-dependent activity with the capability of sensing their local environment and responding accordingly by changing to active form from inactive.
Who invested in Bonum Therapeutics
6 investors across 1 round
See all investors in Bonum Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 15, 2022
Amount
$45M
Investors
Questions about Bonum Therapeutics
Who invested in Bonum Therapeutics?
Bonum Therapeutics has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Bonum Therapeutics raised?
Bonum Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Bonum Therapeutics last raise money?
Bonum Therapeutics's most recent round on record is a Series A, in Nov 2022.
What does Bonum Therapeutics do?
Based in Seattle, US, and founded in 2021, Bonum Therapeutics, Inc.
Where is Bonum Therapeutics headquartered?
Bonum Therapeutics is headquartered in Seattle, US.
Which VCs invest in companies like Bonum Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Bonum Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Bonum Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.